hit counter

GLP-1 Stroke Review Finds Prevention Signal, No Acute Neuroprotection Proof

MHD featured image for GLP-1 receptor agonists and stroke neuroprotection.

A 2026 review concluded that GLP-1 receptor agonists have plausible stroke biology and modest prevention signals, but current human evidence does not support routine use as acute ischemic stroke neuroprotection.1 The useful clinical split is prevention in cardiometabolic patients vs. acute brain-rescue treatment after stroke onset. Research Highlights Acute neuroprotection is not established: the 2026 …

Read more

Levetiracetam After Stroke: 9 Fewer Deaths in Older Adults

MHD featured image for levetiracetam continuation, post-stroke seizure prevention, and 90-day survival in older adults.

A 2026 Medicare target-trial emulation found continued levetiracetam after acute ischemic stroke was associated with 53 vs. 62 deaths per 1,000 over 90 days, a risk difference of −9 deaths per 1,000 favoring continuation. Research Highlights Survival signal: continued levetiracetam after an initial month of post-stroke use was linked to 53 deaths per 1,000 vs. …

Read more